Australia markets closed
  • ALL ORDS

    7,771.80
    +43.30 (+0.56%)
     
  • ASX 200

    7,558.10
    +46.50 (+0.62%)
     
  • AUD/USD

    0.7053
    -0.0029 (-0.40%)
     
  • OIL

    75.31
    -0.57 (-0.75%)
     
  • GOLD

    1,916.10
    -0.20 (-0.01%)
     
  • BTC-AUD

    33,179.36
    -840.86 (-2.47%)
     
  • CMC Crypto 200

    533.82
    -11.50 (-2.11%)
     
  • AUD/EUR

    0.6471
    -0.0015 (-0.22%)
     
  • AUD/NZD

    1.0903
    -0.0026 (-0.24%)
     
  • NZX 50

    12,197.15
    +44.99 (+0.37%)
     
  • NASDAQ

    12,803.14
    +440.04 (+3.56%)
     
  • FTSE

    7,819.93
    -0.23 (-0.00%)
     
  • Dow Jones

    34,053.94
    -39.02 (-0.11%)
     
  • DAX

    15,378.57
    -130.62 (-0.84%)
     
  • Hang Seng

    21,660.47
    -297.89 (-1.36%)
     
  • NIKKEI 225

    27,509.46
    +107.41 (+0.39%)
     

Twist Bioscience to Present at 5th Annual Evercore ISI HealthCONx Conference

Company to host investors at the Factory of the Future on November 29

SOUTH SAN FRANCISCO, Calif., November 23, 2022--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, will host a fireside chat and one-on-one meetings at the 5th Annual Evercore ISI HealthCONx Conference on Wednesday, November 30th at 4:20 p.m. Eastern Time.

The presentation will be webcast live and can be accessed by visiting the "Investor Calendar" page of the investor relations section of the company's website here. A replay of the presentation will be archived for a period of 30 days following the conclusion of the live events.

Twist will host investors at its Factory of the Future outside of Portland, OR and share prepared remarks on November 29, 2022. The company remarks as well as question and answer session will be webcast live at 12:00 p.m. Eastern Time and can be accessed by visiting the "Investor Calendar" page of the investor relations section of the company's website here. A replay of the event will be archived for a period of 14 days following the conclusion of the live events.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by "writing" DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on Twitter | Facebook | LinkedIn | YouTube

View source version on businesswire.com: https://www.businesswire.com/news/home/20221123005082/en/

Contacts

For Twist Bioscience
Angela Bitting
SVP, Corporate Affairs
925- 202-6211
media@twistbioscience.com